Research Advances

A Phase II multicenter study in China has found that the chemotherapy combination of nab-paclitaxel and S-1 (SnP) may be an effective and well-tolerated treatment for patients with locally advanced pancreatic cancer. The regimen could provide an alternative for patients who are unable to tolerate more intensive therapies such as mFOLFIRINOX. Among 60 patients with […]

Researchers are gaining new insights into why pancreatic ductal adenocarcinoma (PDAC), one of the deadliest forms of cancer, remains highly resistant to immunotherapy. A recent review highlights the complex roles of tumor-infiltrating B cells (TIBs) and tertiary lymphoid structures (TLSs), which can either support or suppress the body’s immune response against cancer. The analysis found

A new study has identified a promising strategy to improve natural killer (NK) cell therapy for pancreatic cancer, one of the deadliest and most treatment-resistant cancers. Pancreatic tumors often evade immune attack by using HLA class I molecules to suppress NK cell activity, allowing cancer cells to survive and grow. Researchers found that using HLA-mismatched

Researchershave created the most detailed map to date of meningioma, the most common brain tumor in adults. The study found that the tumor’s surrounding environment, particularly immune cells known as myeloid cells, plays a major role in determining how the cancer grows, returns, and responds to treatment. Using advanced technologies such as single-cell sequencing and

Researchers reported validation of a liquid biopsy-based model that predicts overall survival in recurrent ovarian cancer. The model uses a combination of blood protein markers and clinical factors to improve patient risk stratification and guide future research. The analysis was based on data from the phase 3 ANITA/ENGOT-OV41/GEICO 69-O trial, testing an 8-variable model in

A new multi-omics study has identified three molecular subtypes of colorectal cancer (CRC), with one subtype, known as CS3, showing strong potential for predicting response to immunotherapy. Researchers analyzed genetic, epigenetic, and molecular data and found that CS3 tumors are highly mutated, genomically unstable, and rich in immune activity. Importantly, CS3 includes a subset of

Researchers have found that Tumor Treating Fields (TTFields), a therapy that uses low-intensity electric fields, may help make pancreatic cancer more vulnerable to both chemotherapy and the immune system. In a preclinical study, TTFields were tested alone and in combination with standard chemotherapy using gemcitabine and nab-paclitaxel. The treatment significantly reduced levels of c-Myc, a

A new review explains how the human microbiome—the trillions of microbes living in the gut, mouth, and skin—can influence cancer development and treatment outcomes. When balanced, these microbes help regulate immunity and metabolism, but when disrupted, they can cause chronic inflammation that damages DNA and promotes tumor growth. Specific bacteria have been linked to different

A new study has clarified the role of NOTCH1 in head and neck squamous cell carcinoma (HNSCC), showing that it functions as a tumor suppressor rather than an oncogene. Researchers found that activating NOTCH1 signaling in both mutated and wild-type cancer cells reduced tumor growth, lowered cancer stem cell activity, and triggered changes linked to

Scientists have identified a newly discovered cellular recycling system that helps cells rapidly switch which proteins they produce, with important roles in both sperm development and cancer. The study shows that cells often store “silent” messenger RNAs (mRNAs) that are not immediately translated into proteins. A protein called MEX3D acts as a master switch that